On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
FridayDec 04, 2020 12:21 pm

NetworkNewsBreaks – Marijuana Company of America, Inc. (MCOA), Cannabis Global (CBGL) Issue Joint Shareholder Letter

Marijuana Company of America (OTCQB: MCOA), based in Escondido, California and focused on cannabidiol (“CBD”) products, together with Cannabis Global Inc. (OTC: CBGL), an innovation-oriented company investing in disruptive cannabis and hemp-related technologies, on Thursday issued a joint letter to shareholders. Recently, the companies entered into an agreement wherein each became the largest shareholder of the other. As a result, CBGL owns 650 million shares of MCOA and MCOA owns just over 7.2 million shares of CBGL. The transaction intends to promote the growing common interests and collaborations between the two pioneering cannabis and CBD operations. The update reads, “Both…

Continue Reading

FridayDec 04, 2020 11:56 am

NetworkNewsBreaks – CannAssist International Corporation’s (CNSC) Reg. A Offering Capital to Boost Continued Brand Expansion, Benchmarks

CannAssist (OTCQB: CNSC), a unique, enhanced cannabidiol (“CBD”) company, recently announced SEC approval of its Reg. A+ Tier 2 Filing as of Oct. 13, 2020, and an opportunity for investors to purchase shares at a set price stated in filing. “CannAssist International is building digital platforms, implementing a Brand PR and Sales/Marketing Campaign, expanding distribution, building inventory and enhancing the Xceptol brand,” said CannAssist’s CEO and Founder Mark Palumbo. “Gaining approval for the CNSC Reg A offering is an exciting milestone for us as it opens doors for new investors. The capital will help CannAssist’s continued expansion of the brand…

Continue Reading

FridayDec 04, 2020 11:13 am

NetworkNewsBreaks – Brain Scientific Inc. (BRSF) to Showcase NeuroCap(TM) at AES2020

Brain Scientific (OTCQB: BRSF), a neurology-focused medical device and software company, today announced that it will participate in AES2020 – the all-new virtual event for epilepsy professionals in academia, clinical practice, industry and advocacy. Slated to take place on Dec. 4–8, 2020, the American Epilepsy Society's Annual Meeting is the largest meeting and exhibition in the world to share common scientific and clinical interests in epilepsy and clinical neurophysiology. “Brain Scientific has successfully taken part in AES conferences before, and this year we will have a virtual booth at this important event. We will be showing the new version of…

Continue Reading

FridayDec 04, 2020 10:54 am

NetworkNewsBreaks – Sanwire Corp.’s (SNWR) Intercept Music Launches 25 Online Retail Stores for Intercept PLUS Artists

Sanwire (OTC: SNWR), focused on technologies for the entertainment industry, together with its wholly owned subsidiary Intercept Music Inc., today announced the completion of 25 online retail stores for its Intercept PLUS artists. Per the update, the online retail stores provide artists the ability to sell branded merchandise to their fans. Artists choose the products they wish to sell and promote, including logos, designs, prints, etc., and Intercept takes care of the rest for a share of the profits. “With the complete ban on live performances, musicians are losing out on their biggest revenue stream, and that in turn affects…

Continue Reading

FridayDec 04, 2020 10:33 am

NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Commercial Launch Date for ImmunaZin(TM)

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of pressure-based instruments, consumables and platform solutions to the worldwide biotechnology and other industries, today announced that its proposed acquisition partner Cannaworx Inc. has set December 2020 as the commercial launch date for its patented immune booster supplement: ImmunaZin(TM). According to the update, Cannaworx believes that post-launch, this product will be one of very few over-the-counter, FDA-registered, hemp seed oil-enhanced supplements with an immune-booster claim. “Our team is excited to be joining a company bringing such an important and valuable product to market, particularly considering its potential role in…

Continue Reading

FridayDec 04, 2020 10:13 am

NetworkNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) to Provide QuadSight(R) Solution in Framework for AWARD Project

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, today announced that the European Commission, through the Horizon 2020 framework program, has awarded a funding grant of nearly 20 million Euro for the All Weather Autonomous Real logistics operations and Demonstrations (“AWARD”) consortium to develop and operate safe autonomous heavy-duty vehicles in harsh weather conditions in a variety of different scenarios. As part of the project, Foresight will provide its QuadSight(R) multispectral vision solution, and is expected to receive approximately one million USD. According to the update, the AWARD project will be rolled out in 2021…

Continue Reading

FridayDec 04, 2020 9:43 am

NetworkNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Issues Update on Portfolio Companies

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, on Thursday provided an update on three portfolio companies: TerrAscend, YSS and Dynaleo. "Over the past month, our portfolio companies have made several announcements that demonstrate their continued momentum and growth in their respective markets," said Canopy Rivers’ Narbe Alexandrian. "We believe that this growth is a testament to the theses behind these investments, and we look forward to seeing their progress continue into 2021." To view the full press release, visit https://nnw.fm/IpDzw About Canopy Rivers Inc. Canopy Rivers is a venture capital firm specializing in cannabis…

Continue Reading

ThursdayDec 03, 2020 3:24 pm

NetworkNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) to Present at LD Micro Main Event

180 Life Sciences (NASDAQ: ATNF, ATNFW), a clinical-stage biotechnology company with its lead indication in phase 2b/3, focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today announced that it will participate in the LD Micro Virtual Main Event 2020 Conference. According to the update, 180 Life Sciences CEO Dr. James Woody is scheduled to present at 1:40 p.m. EST on Tuesday, Dec. 15. Interested parties should visit https://nnw.fm/fw8fo to register for the event. The 2020 LD Micro Main Event will feature a new and unique format with companies presenting for 10…

Continue Reading

ThursdayDec 03, 2020 2:26 pm

NetworkNewsBreaks – Mass Megawatts Wind Power Inc. (MMMW) Provides Updates on Growth Objectives

Mass Megawatts Wind Power (OTC: MMMW) has reported that it is in its best cash position in years as it works toward achieving new corporate growth objectives. The company anticipates significant progress as it moves forward with the growth of new product manufacturing. Furthermore, commercial sales of its new solar tracker product have created renewed optimism and revenue. Solar trackers reduce the cost of solar-powered electricity, and the solar tracker market is projected to reach more than $3 billion by 2025. Mass Megawatts offers a product that costs less than other available solar trackers, so the company sees an opportunity…

Continue Reading

ThursdayDec 03, 2020 2:06 pm

NetworkNewsBreaks – Grey Cloak Tech Inc. (GRCK) Announces Positive Clinical Study Results for ‘HERHEART(TM)’

Grey Cloak Tech (OTCQB: GRCK) (soon to be Healthy Extracts Inc.), a company engaged in proprietary development of natural plant-based formulations and sales and distribution of clinically proven cardiovascular and neuro products, today announced that the newly released clinical study of BergaMet NA’s HERHEART(TM) product produced incredible results. In addition, the company announced the appointment of internationally renowned Dr. Nesochi Okeke-Igokwe MD., M.S to its medical advisory board to promote women’s health. “Cardiovascular disease is the number one cause of death for women in the United States,” said Duke Pitts, CEO of BergaMet NA. “HERHEART was specifically formulated to fill…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217